Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Double-blind Pilot Study Comparing Flecainide CR and Placebo in the Early Treatment of Patients With a Documented First Episode of Atrial Fibrillation.

NCT00408473 is registered in ClinicalTrials.gov with MEDA Pharma GmbH & Co. KG as lead sponsor.

NCT NCT00408473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00408473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Double-blind Pilot Study Comparing Flecainide CR and Placebo in the Early Treatment of Patients With a Documented First Episode of Atrial Fibrillation.
Lead sponsor
MEDA Pharma GmbH & Co. KG
Phase
Phase 4
Overall status
Terminated
Start date
Not reported
Completion date
Not reported
Enrollment
256
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation